OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2144-2176
Open Access | Times Cited: 12
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2144-2176
Open Access | Times Cited: 12
Showing 12 citing articles:
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS
René Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Neurology (2025) Vol. 104, Iss. 3
Closed Access
René Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Neurology (2025) Vol. 104, Iss. 3
Closed Access
Central American and Caribbean Consensus for the Treatment of MS, NMOSD, and MOGAD
Deyanira Ramírez, Fernando Gracia, Alejandro Jose Diaz Jimenez, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106334-106334
Closed Access
Deyanira Ramírez, Fernando Gracia, Alejandro Jose Diaz Jimenez, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106334-106334
Closed Access
Risk of MS relapse and deterioration after COVID-19: A systematic review and meta-analysis
Homa Seyedmirzaei, Dorsa Salabat, Sara KamaliZonouzi, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 83, pp. 105472-105472
Closed Access | Times Cited: 3
Homa Seyedmirzaei, Dorsa Salabat, Sara KamaliZonouzi, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 83, pp. 105472-105472
Closed Access | Times Cited: 3
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab
René Carvajal, Ana Zabalza, Pere Carbonell‐Mirabent, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246345-e246345
Open Access | Times Cited: 3
René Carvajal, Ana Zabalza, Pere Carbonell‐Mirabent, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246345-e246345
Open Access | Times Cited: 3
COVID-19 and multiple sclerosis: challenges and lessons for patient care
Luca Prosperini, Georgina Arrambide, Elisabeth Gulowsen Celius, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 100979-100979
Open Access | Times Cited: 2
Luca Prosperini, Georgina Arrambide, Elisabeth Gulowsen Celius, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 100979-100979
Open Access | Times Cited: 2
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients
René Carvajal, Carmen Tur, Xavier Martínez‐Gómez, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1841-1848
Open Access | Times Cited: 6
René Carvajal, Carmen Tur, Xavier Martínez‐Gómez, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1841-1848
Open Access | Times Cited: 6
Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis
Theodoros Marantos, Evdoxia Kyriazopoulou, Vasileios Lekakis, et al.
Journal of the Neurological Sciences (2023) Vol. 456, pp. 122852-122852
Closed Access | Times Cited: 4
Theodoros Marantos, Evdoxia Kyriazopoulou, Vasileios Lekakis, et al.
Journal of the Neurological Sciences (2023) Vol. 456, pp. 122852-122852
Closed Access | Times Cited: 4
Recommandations de la Société francophone de la sclérose en plaques « Vaccinations et sclérose en plaques » : mise à jour 2024
Christine Lebrun‐Frénay, Clarisse Carra‐Dallière, Céline Louapre, et al.
Pratique Neurologique - FMC (2024) Vol. 15, Iss. 2, pp. 105-113
Closed Access
Christine Lebrun‐Frénay, Clarisse Carra‐Dallière, Céline Louapre, et al.
Pratique Neurologique - FMC (2024) Vol. 15, Iss. 2, pp. 105-113
Closed Access
Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders
Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126061-126061
Closed Access
Mohammad Yazdan Panah, Saeed Vaheb, Yousef Mokary, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126061-126061
Closed Access
Mark Colin Gissler, Felix S.R. Picard, Timoteo Marchini, et al.
(2024), pp. 201-240
Closed Access
XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)
Óscar Fernández, Xavier Montalbán, Eduardo Agüera, et al.
Revista de Neurología (2024) Vol. 79, Iss. 02, pp. 51-51
Open Access
Óscar Fernández, Xavier Montalbán, Eduardo Agüera, et al.
Revista de Neurología (2024) Vol. 79, Iss. 02, pp. 51-51
Open Access
Novel polymer-based hydrogels of recent research in drug delivery for disease treatment related to SARS-CoV-2 virus
Hoc Thang Nguyen, Van Phuc Nguyen, Tran Thi Tu Nhi, et al.
eXPRESS Polymer Letters (2023) Vol. 18, Iss. 2, pp. 160-192
Open Access | Times Cited: 1
Hoc Thang Nguyen, Van Phuc Nguyen, Tran Thi Tu Nhi, et al.
eXPRESS Polymer Letters (2023) Vol. 18, Iss. 2, pp. 160-192
Open Access | Times Cited: 1
